| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| J0585 |
Injection,onabotulinumtoxina |
16,400 |
14,513 |
$20.47M |
| Q9992 |
Buprenorphine xr over 100 mg |
4,161 |
3,296 |
$5.90M |
| J1726 |
Makena, 10 mg |
2,321 |
1,584 |
$5.32M |
| J2357 |
Omalizumab injection |
2,328 |
1,990 |
$4.95M |
| Q9991 |
Buprenorph xr 100 mg or less |
3,364 |
2,628 |
$4.93M |
| J2315 |
Naltrexone, depot form |
3,410 |
3,055 |
$4.42M |
| J2323 |
Natalizumab injection |
361 |
260 |
$2.02M |
| J2182 |
Injection, mepolizumab, 1mg |
831 |
592 |
$1.99M |
| J0517 |
Inj., benralizumab, 1 mg |
386 |
340 |
$1.68M |
| J7323 |
Euflexxa inj per dose |
912 |
695 |
$1.04M |
| J7318 |
Inj, durolane 1 mg |
658 |
550 |
$785K |
| J0897 |
Denosumab injection |
582 |
510 |
$745K |
| Q5103 |
Injection, inflectra |
141 |
115 |
$411K |
| J2356 |
Inj tezepelumab-ekko, 1mg |
78 |
41 |
$232K |
| J7328 |
Gelsyn-3 injection 0.1 mg |
80 |
71 |
$105K |
| J3490 |
Drugs unclassified injection |
61 |
49 |
$59K |
| 90378 |
|
101 |
55 |
$8K |
| J7507 |
Tacrolimus imme rel oral 1mg |
254 |
177 |
$905.14 |
| Q0511 |
Sup fee antiem,antica,immuno |
453 |
391 |
$624.24 |
| S5000 |
Prescription drug, generic |
61 |
56 |
$337.94 |
| Q0512 |
Px sup fee anti-can sub pres |
412 |
241 |
$173.34 |